During the last two decades, remarkable improvements have been registered in dealing with cancer, in relation to both early diagnosis and therapeutic strategies, the latter being enhanced by the widespread use of combined approaches (chemotherapy, radiotherapy, and surgery). For example, in regard to breast cancer, largely due to striking improvements in early detection and treatment, the survival rate at 5 years post-diagnosis, independently of the cancer stage, is almost 88%. Consequently, in western countries, new scenarios are being faced regarding cancer survival; cancer survivors account for 3-4% of the general population (l); most of these (about 61%) are at least 65 years old. The aging trends combined with the rising cure rates allow to forecast an extraordinarily increased number of elderly patients living for a long time beyond the diagnosis and treatment of cancer. At present, about 64% of the adults who survive cancer can be expected to be alive after five years from the end of the cancer treatment, whereas in the 70's this rate was estimated below 50% (l); as for paediatric patients, five-year survival rates have risen to approximately 75%, clearly a high rate if compared with the mid-1970's trend (fewer than 65%) (2) .
On the other hand, it has to be recognised that several lifestyle factors, such as high caloric intake or sedentary lifestyle, not only are known to dramatically increase the risk of developing cancer, but could also affect both the disease-free and the overall survival rates once cancer has been diagnosed and, could also significantly influence long-term effects, late effects and co-morbidities which cancer survivors often have to face.
The impact of post-cancer is becoming more and more significant, being associated with several long-term physical and mental health consequences. Cancer survivors undergo several physical and psychological strains both from the disease and the subsequent treatments; compared with the general population, cancer survivors are clearly at a greater risk for other diseases, such as second primary and/or recurring cancer, but also sarcopenic obesity, metabolic syndrome and the related cardiovascular diseases, osteoporosis, decreased fatigue endurance, accelerated functional impairment and postural dysfunction (I). Such risks are due to multifactorial causes: not only chemo-and radiotherapy for cancer treatment, and genetic predisposition, but also for the arising and/or perpetuation of inappropriate lifestyle behaviour (1). One of the main goals of the current cancer survival research is the identification of appropriate interventions, such as rehabilitation, motor exercise and physical activity, which can be effective in antagonizing premature mortality and improving a patient's quality of life. In this regard, particular attention has to be paid to specific lifestyle changes, which could be of critical importance in order to achieve such results.
SARCOPENIC OBESITY
Obesity acts as a risk factor for various types of cancer, such as breast cancer in postmenopausal women, endometrial carcinoma, colon carcinoma, oesophagus carcinoma and renal cell carcinoma (I). Moreover, relating to breast cancer, the prognosis after the onset of the disease is also worse in obese women and/or in women who have gained weight after receiving diagnosis and treatment, than in normal body weight women. In fact, although certain cancer types are associated to rapid weight loss conducing to cachexia, i:e. lung cancer (3) (4) and pancreatic cancer (5), both during and after chemotherapy for cancer treatment additional weight gain has been described in other cancer types, such as breast cancer, prostate cancer, paediatric brain tumors, testicular cancer and several gastrointestinal cancers. Important chronic diseases associated with weight gain might overlap with those which are connected to cancer itself, for instance metabolic syndrome (including type 2 diabetes, hypertension and other cardiovascular diseases) and certain types of cancer, both recurrent and primary, occurring in the same organ (i.e. colon carcinoma or breast cancer) or in other sites (i.e. leukaemia and several solid tumors) (1). Weight gain not only is a common side effect of adjuvant chemotherapy, but might also be related to hormonal therapy, as well as to dietetic and lifestyle changes (6) . Also, paediatric cancer long-term survivors (especially female) are prone to such chronic problems, including obesity/high body mass index, significantly higher mean body fat, decreased total energy expenditure, decreased levels of physical activity and reduced energy expenditure with low intensity exercise.
This pattern of weight gain, characterized by dramatic changes in the body composition balance, i.e. a specific increase in fat mass without a concomitant achievement in lean tissue, or even its loss, is termed sarcopenic obesity (7) . Sarcopenia refers to the involuntary skeletal muscle loss which leads, by decreasing muscular strength and fatigue endurance, to functional impairment, physical disability and consequential loss of autonomy (8) . The decrease in muscle mass and strength is mainly caused by a decline in the protein synthesis, particularly that of myosin heavy chains causing atrophy of muscle type lIa fibers (9) . Acute manifestation of sarcopenic obesity is connected to corticosteroid therapy, hypopituitarism, neuromuscular diseases, hypogonadism, bed rest, and prolonged physical inactivity (7, 6) . Moreover, muscle loss and/or fat mass gain are linked to osteoporosis (see below) (10) . It is clear that such a condition is bound to affect both the disease-free and overall survival, being an established risk factor for cardiovascular disease, diabetes and other comorbid conditions (11).
Rehabilitation, in terms of resistance training physical activity, is considered as being the basis for preventing and treating sarcopenic obesity (7, 6) therefore improving fatigue endurance and life quality.
INSULIN RESISTANCE/METABOLIC SYNDROME
The most striking health concerns associated with the metabolic syndrome in cancer survivors are insulin resistance, with co-occurring hyperinsulinemia and/or eventual diabetes (12) .
Insulin resistance is a worldwide risk factor, not only for malignancies but also for cardiovascular disease (13) . Despite the existence of conflicting definitions, metabolic syndrome has at least five basic criteria: hyperglycemia, abdominal obesity, elevated serum triglyceride level, low HDLcholesterol level (dyslipidemia) and hypertension (14) . Each of the above criteria, if taken alone, is a cancer-related risk factor, leading to a multiplied effect if associated to the others. Insulin, which exerts several metabolic effects, stimulates cellular growth both directly and indirectly, i.e. by enhancing the production of the mitogenic Insulin-like Growth Factor, resulting in a pathological cell (mostly epithelial) proliferation. Hyperglycaemia, which appears during the uncompensated phase of insulin resistance, is positively involved in tumor growth by several pathways, such as the nonenzymatic glycation of protein structures; some of the these, once glycated, enhance the liberation of free radicals, growth factors and cytokines (15) . Not surprisingly, the cancer patients sub-group with hyperglycemia or type 2 diabetes present cancer recurrence, metastatic spreading and fatal outcome rates higher than the metabolic syndrome-free subgroup. Thus, aimed efforts are needed in preventing and/or treating insulin resistance in cancer survivors. The association of correct physical activity/rehabilitation with an appropriate diet regimen and weight loss maintains and/or increases insulin sensitivity, and decreases the risk for cardiovascular complications and secondary malignancies and/or recurrences (16) .
OSTEOPOROSIS
Osteoporosis, with its related increased risk of fractures, is an extremely common condition in cancer survivors, rising even to 80% of the patients (17, 1) . In long-term adjuvant breast cancer, therapy bone loss is frequently reported due to the postmenopausal condition of many patients, implying the age-related oestrogen deficiency and the additional effect of estrogen-depleting therapies. In paediatric female patients, chemo-and radiotherapy can cause early menopause and its associated side effect of osteoporosis (18) . In prostate cancer patients, androgen deprivation long term therapy promotes the risk of osteoporosis, reducing both survival and life quality (10) . Aiming to prevent and treat osteoporosis, various options should be studied and tailored to the specific needs of cancer survivors, including rehabilitation (1, 10), vitamin D and calcium supplementation, and the use of bisphosphonates (10) .
CANCER-RELATED FATIGUE
Cancer-related fatigue, either as a symptom or a syndrome, depending on criteria for diagnosis, occurs in 20-30% of long-term cancer survivors, arising to a 80-90% peak during the treatment and at the end of a patient's life. There is evidence for a link between inflammation and cancer-related fatigue. Both cancer and its treatment can activate the pro-inflammatory cytokine network and induce long-term changes in immune homeostasis, including elevations in soluble markers of inflammation (IL-Ira, IL-6, sTNF-RII and neopterin), alterations in immune cell subsets (particularly elevations in CD4+ T lymphocites and CD56+ effector T lymphocites), changes in expression and signalling of Toll-like receptors, and latent virus reactivation. Cancer-related changes in neuroendocrine function may also contribute to chronic inflammation, particularly impairment in glucocorticoid production, resulting in loss of control of the inflammatory cascade. Associated factors such as depression, pain, insomnia, dyspnoea, anaemia and de-conditioning worsen cancer-related fatigue and should be treated if present. In addition, individual polymorphisms may increase the risk for chronic inflammation following cancer diagnosis and treatment, including SNPs in genes that control pro-inflammatory cytokine expression and activity leading to alterations in the hypothalamicpituitary-adrenal (HPA) axis function. At this time, pharmacologic options include recombinant erythropoietin, psycho-stimulants, corticosteroid, non-steroid anti-inflammatory drugs and L-camitine (18) (19) (20) . Future developments are expected in the field of targeted therapies, i.e. cytokine antagonists, TNF blockade, behavioural and mind-body interventions. In cancer patients, physical activity has been shown to reduce fatigue and other somatic complaints and improve several scores of psychological distress (obsessive-compulsive traits, fear, interpersonal sensitivity and phobic anxiety). It may decrease the duration of neutropenia or thrombocytopenia, the severity of diarrhoea and chronic pain, and the duration of hospitalization. Integrated exercise has been shown to improve physical functioning and peak oxygen consumption leading to a reduction of fatigue symptoms (21) .
THE INTERPLAY OF DIET, PHYSICAL ACTIVITY, AND WEIGHT CONTROL
Research on cancer survivors has demonstrated that exercise increases muscle strength and cardiovascular fitness, improves physical functioning, helps to control body weight, decreases body fat, and lowers blood pressure. Exercise may also alleviate symptoms that interfere with the daily life of cancer patients and survivors, such as fatigue, nausea, and sleep disturbance. It has been proposed that exercise may even reduce the risk of cancer recurrence, second primary cancers and other chronic diseases, as well as prolong survival. Associations between exercise and emotional well-being have been documented in observational research and quasi-experimental and randomized studies involving cancer patients and survivors, although most of these trials could be biased by the possible emotional benefits deriving from factors other than exercise, such as increased care from the intervention staff (22) .
Moreover, body weight control through regular physical activity reduces the risk of breast cancer (23) , and halves the risk of death in breast cancer patients (24) ; cancer death risk is significantly lower in men with a physically active lifestyle compared to those with a sedentary lifestyle. Dietary energy restriction can reduce body weight, improving the psychological condition in obese women and breast cancer survivors, probably by activating the above-described mechanisms. Dietary fat intake interventions associated with weight loss can also evoke a significant reduction in serum oestrogen levels in pre-and post-menopausal women (25) .
The dietary energy restriction effects might be enhanced by the implementation of adjunctive exercise therapy. Thus, physical rehabilitation and dietetic programs, like those for cardiac rehabilitation, seem effective in managing, controlling or preventing adverse outcomes occurring in cancer survivors. Not surprisingly, rehabilitation programs developed in order to improve the physical efficiency of patients affected by mobility impairment following breast cancer treatment, have been shown to be effective in controlling body weight, so that they improve life quality, reduce the impact of chronic fatigue and premature menopause-related osteoporosis, and prevent or control both concomitant and future comorbidities (26) (27) (28) .
It is important to underline that the ability to perform physical activity is associated with the preservation of muscular strength, a critical factor for a correct postural alignment allowing a correct physical movement. In cancer patients, the reduction of muscular strength might clearly be avoided by generating muscular efforts, with the eventual drawback of inducing articular stress; nevertheless, such a result could also be achieved by means of advanced techniques such as selective vibratory neuromuscular apparatus stimulation. In fact, a fairly simple procedure able to influence force contraction is muscle vibration, which has been proved to be a powerful mechanical stimulus activating the proprioceptive sensory system. It consists of the arousing of Ia afferent signals from the neuromuscular spindles, a phenomenon which activates a large number of alpha motoneurons, leading to the recruitment of previously inactive muscular fibres in the contraction process. Interestingly, the adaptive answers to vibrations in the neuromuscular apparatus increase the contraction vigour, not only in the directly pressed muscles, but also In the adjacent ones. The vibratory stimulus, beyond activating the neuromuscular spindles (responsive to the variation of length), could even have an action on the Golgi tendon organs (responsive to the variation of tension) (29) . The consequent stimulation of spinal and supraspinal functions causes a better nervous control ofmuscular fibre recruitment. The local vibratory stimulation leads to a significative increase of the muscular tone and vigour. Furthermore, the vibrations have been shown to produce a positive effect on the muscle metabolism, an analgesic muscular effect and an increase in local blood circulation, as well as in bone density.
Such effects, however, vanished soon after the stimulus' end. More recently, many authors have shown that localized effects of vibration can persist for some minutes after the vibrations have ended. Both exposure time (10-15 minutes) and frequency (>120Hz) (30) (31) seem to be crucial. In another study, a long lasting change in the straight head perception has been reported after vibration of the neck muscle (30) . It has been shown that a shortlasting vibratory treatment based on sequences of mechanical-sonorous oscillations improves the right side extensor muscle force of subjects who have undergone therapeutic immobilisation. This improvement occurs soon after treatment and persists during the following 6 months (32).
CONCLUSIONS
The cancer survivor's management requires a network of different interventions which have been shown to be effective in modifying, among others, the hormone levels, the immune response and the free radicals damage. The rehabilitative context, characterized by an appropriate motor exercise planning, if combined with an equally suitable prevention strategy, determines an interaction of great interest leading to significant improvements in physical functioning, peak oxygen consumption and fatigue endurance. Rehabilitative physical exercise is an effective tool in order to antagonize the cancer survivor's tendency to sarcopenic obesity, insulin resistance and/or metabolic syndrome, osteoporosis and cancer-related fatigue, leading to significant improvements in QOL, cardio respiratory fitness, motor functioning, mood and mental health in cancer survivors. Thus, one of the next research goals should be to ascertain the type of motor exercise most suitable for the needs of the individual cancer survivor, and the ideal lifestyle conditions so as to grant the maximum exploitation of the above-mentioned exercise. In this way it will be possible to produce an innovativewelfare model involving the different cancer therapeutic options in concert with an appropriate combination of lifestyle and rehabilitation interventions,tailored to the individual patient's peculiarities. Such a model should be constantly under the oncologist's supervision.
